227 related articles for article (PubMed ID: 33822577)
1. Opportunities and Challenges in Developing a
Jumani RS; Blais J; Tillmann HC; Segal F; Wetty D; Ostermeier C; Nuber N; Lakshman J; Aziz N; Chandra R; Chen WH; Chappell CL; Diagana TT; Manjunatha UH
ACS Infect Dis; 2021 May; 7(5):959-968. PubMed ID: 33822577
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic screening techniques for
Love MS; McNamara CW
Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
Caravedo MA; White AC
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
[TBL] [Abstract][Full Text] [Related]
5. Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.
Rahman SU; Mi R; Zhou S; Gong H; Ullah M; Huang Y; Han X; Chen Z
Acta Trop; 2022 Feb; 226():106273. PubMed ID: 34906550
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
7. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
Manjunatha UH; Chao AT; Leong FJ; Diagana TT
ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
[TBL] [Abstract][Full Text] [Related]
9. Emerging treatment options for cryptosporidiosis.
Love MS; Choy RKM
Curr Opin Infect Dis; 2021 Oct; 34(5):455-462. PubMed ID: 34261904
[TBL] [Abstract][Full Text] [Related]
10. Cryptosporidium and Giardia Infections in Children: A Review.
Mmbaga BT; Houpt ER
Pediatr Clin North Am; 2017 Aug; 64(4):837-850. PubMed ID: 28734513
[TBL] [Abstract][Full Text] [Related]
11. A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors.
Jumani RS; Hasan MM; Stebbins EE; Donnelly L; Miller P; Klopfer C; Bessoff K; Teixeira JE; Love MS; McNamara CW; Huston CD
Nat Commun; 2019 Apr; 10(1):1862. PubMed ID: 31015448
[TBL] [Abstract][Full Text] [Related]
12. Use-case scenarios for an anti-Cryptosporidium therapeutic.
Ashigbie PG; Shepherd S; Steiner KL; Amadi B; Aziz N; Manjunatha UH; Spector JM; Diagana TT; Kelly P
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009057. PubMed ID: 33705395
[TBL] [Abstract][Full Text] [Related]
13. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
Swale C; Bougdour A; Gnahoui-David A; Tottey J; Georgeault S; Laurent F; Palencia A; Hakimi MA
Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694928
[No Abstract] [Full Text] [Related]
14. Novel treatment strategies and drugs in development for cryptosporidiosis.
Chavez MA; White AC
Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
[TBL] [Abstract][Full Text] [Related]
15. New Tools for Cryptosporidium Lead to New Hope for Cryptosporidiosis.
Ward HD
Trends Parasitol; 2017 Sep; 33(9):662-664. PubMed ID: 28750950
[TBL] [Abstract][Full Text] [Related]
16. Management of a Cryptosporidium hominis outbreak in a day-care center.
Vandenberg O; Robberecht F; Dauby N; Moens C; Talabani H; Dupont E; Menotti J; van Gool T; Levy J
Pediatr Infect Dis J; 2012 Jan; 31(1):10-5. PubMed ID: 22094626
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in genetic manipulation of Cryptosporidium.
Vinayak S
Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in children.
Das JK; Ali A; Salam RA; Bhutta ZA
BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S10. PubMed ID: 24564492
[TBL] [Abstract][Full Text] [Related]
19. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment and novel drug target against Cryptosporidium.
Gargala G
Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
